U.S. FDA Launches First Overseas Office in Beijing
This article was originally published in PharmAsia News
Executive Summary
U.S. HHS Secretary Michael Leavitt and U.S. FDA Commissioner Andrew von Eschenbach officially opened the first overseas FDA office Nov. 19 in Beijing in a continuing effort to improve foreign product safety, while the agency faces criticism from the U.S. Congress